[go: up one dir, main page]

MX2019002575A - Microcapsulas biodegradables que contienen material de relleno. - Google Patents

Microcapsulas biodegradables que contienen material de relleno.

Info

Publication number
MX2019002575A
MX2019002575A MX2019002575A MX2019002575A MX2019002575A MX 2019002575 A MX2019002575 A MX 2019002575A MX 2019002575 A MX2019002575 A MX 2019002575A MX 2019002575 A MX2019002575 A MX 2019002575A MX 2019002575 A MX2019002575 A MX 2019002575A
Authority
MX
Mexico
Prior art keywords
filling material
microcapsules containing
biodegradable
containing filling
biodegradable microcapsules
Prior art date
Application number
MX2019002575A
Other languages
English (en)
Inventor
A Rhodes Christopher
Park Kinam
Original Assignee
Akina Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akina Inc filed Critical Akina Inc
Publication of MX2019002575A publication Critical patent/MX2019002575A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Dermatology (AREA)

Abstract

Se describen microcápsulas biodegradables que incluyen una cubierta de polímero biodegradable y un material de relleno. La cubierta de polímero completamente abarca el material de relleno. El material de relleno puede incluir una o más micropartículas biodegradables o un agente terapéutico, o ambos.
MX2019002575A 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno. MX2019002575A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20

Publications (1)

Publication Number Publication Date
MX2019002575A true MX2019002575A (es) 2019-10-30

Family

ID=50341971

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015003665A MX2015003665A (es) 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno.
MX2019002575A MX2019002575A (es) 2012-09-20 2015-03-20 Microcapsulas biodegradables que contienen material de relleno.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2015003665A MX2015003665A (es) 2012-09-20 2013-09-20 Microcapsulas biodegradables que contienen material de relleno.

Country Status (9)

Country Link
US (3) US20150265541A1 (es)
EP (1) EP2897593A4 (es)
JP (2) JP2015532928A (es)
KR (1) KR20150090038A (es)
AU (3) AU2013317899A1 (es)
BR (1) BR112015006087A2 (es)
HK (1) HK1214127A1 (es)
MX (2) MX2015003665A (es)
WO (1) WO2014047439A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889193B2 (en) 2010-02-25 2014-11-18 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
US9327037B2 (en) 2011-02-08 2016-05-03 The Johns Hopkins University Mucus penetrating gene carriers
CA2863632C (en) 2012-01-19 2017-07-11 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
EP2825207B1 (en) 2012-03-16 2020-08-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
WO2013138343A1 (en) 2012-03-16 2013-09-19 The Johns Hopkins University Controlled release formulations for the delivery of hif-1 inhibitors
KR102140989B1 (ko) 2012-05-03 2020-08-04 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
AU2013256064B2 (en) 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US9889208B2 (en) 2012-05-04 2018-02-13 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
WO2014124006A1 (en) 2013-02-05 2014-08-14 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127389A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic enema formulations and methods of use
KR20240126072A (ko) 2015-01-27 2024-08-20 더 존스 홉킨스 유니버시티 점막표면에서 활성제의 향상된 수송을 위한 저장성 하이드로겔 제제
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
CN109562107A (zh) 2016-05-10 2019-04-02 C4医药公司 用于靶蛋白降解的杂环降解决定子体
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
ES2990061T3 (es) 2016-05-10 2024-11-28 C4 Therapeutics Inc Degronímeros espirocíclicos para la degradación de proteínas diana
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
WO2018005552A1 (en) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
CN109789143A (zh) 2016-07-01 2019-05-21 G1治疗公司 基于嘧啶的抗增殖剂
EP3532025B1 (en) 2016-10-28 2021-02-24 Unilever N.V. Personal care compositions comprising surface-modified particles and non-volatile functionalised silicone
EP3532166B1 (en) * 2016-10-28 2020-09-16 Unilever N.V. A personal care composition comprising particles
CA3053818A1 (en) 2017-03-01 2018-09-07 Achillion Pharmaceuticals, Inc. Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disorders
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
JP2021519337A (ja) 2018-03-26 2021-08-10 シー４ セラピューティクス， インコーポレイテッド Ｉｋａｒｏｓの分解のためのセレブロン結合剤
EP3841086B1 (en) 2018-08-20 2025-04-23 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
WO2020051532A2 (en) 2018-09-06 2020-03-12 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
KR102272566B1 (ko) 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
US12496279B2 (en) 2019-04-11 2025-12-16 The Johns Hopkins University Nanoparticles for drug delivery to brain
EA202192738A1 (ru) 2019-04-12 2022-03-17 С4 Терапьютикс, Инк. Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos
EP4107166A4 (en) 2020-02-20 2024-06-26 Achillion Pharmaceuticals, Inc. HETEROARYL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D-MEDIATED DISORDERS
CN119823124A (zh) 2020-03-05 2025-04-15 C4医药公司 用于brd9的靶向降解的化合物
HRP20251397T1 (hr) 2020-05-19 2026-01-02 Pharmacosmos Holding A/S Spojevi koji inhibiraju kinazu ovisnu o ciklinu za liječenje medicinskih poremećaja
EP4216946A4 (en) 2020-09-23 2024-11-13 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
US6599627B2 (en) * 2000-12-13 2003-07-29 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
BRPI0516308A2 (pt) * 2004-10-04 2010-06-15 Qlt Usa Inc composição fluida, métodos de tratamento de uma doença ou disfunção, métodos de liberação local ou sistêmica de um agente biológico, implantes, método de formação de um implante, kit de agente biológico e usos de uma composição fluida
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
KR20080059175A (ko) * 2005-09-07 2008-06-26 사우스웨스트 리서치 인스티튜트 방출속도가 향상된 생분해성 미립자 약제학적 제제
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
US8951567B2 (en) * 2007-09-27 2015-02-10 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
WO2012054498A1 (en) * 2010-10-18 2012-04-26 Case Western Reserve University Polymeric microparticles

Also Published As

Publication number Publication date
JP2019014729A (ja) 2019-01-31
AU2013317899A1 (en) 2015-05-07
KR20150090038A (ko) 2015-08-05
MX2015003665A (es) 2016-03-08
BR112015006087A2 (pt) 2017-07-04
AU2018204552A1 (en) 2018-07-12
EP2897593A1 (en) 2015-07-29
WO2014047439A1 (en) 2014-03-27
US20180185296A1 (en) 2018-07-05
JP2015532928A (ja) 2015-11-16
EP2897593A4 (en) 2016-04-06
AU2013317899A8 (en) 2015-05-28
AU2020202735A1 (en) 2020-05-14
HK1214127A1 (zh) 2016-10-07
US20150265541A1 (en) 2015-09-24
US20200390715A1 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
MX2019002575A (es) Microcapsulas biodegradables que contienen material de relleno.
ZA201506934B (en) Aerosol comprising distributing agent and a medicament source
IL237101B (en) A secondary part, a system that includes a dental implant and the secondary part, and a package that includes the system
PL2846835T3 (pl) Kształtowana termicznie, odporna na manipulacje farmaceutyczna postać dawkowania zawierająca cynk
SG11201501793SA (en) Water-absorbent resin, water-absorbent material, and water-absorent article
GB201303690D0 (en) Microcapsules and contrete containing the same
AU346743S (en) Cap for a container
ZA201500252B (en) Portion capsule having an identification on the inner periphery thereof
ZA201301242B (en) Containers and overwraps comprising thermoplastic polymer material,and related methods for making the same
AU201714610S (en) Fragrance Capsule
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
IL240592B (en) A medical device for the treatment of aneurysm, which includes an antithrombotic agent
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
GB201307917D0 (en) Vaporisable material plug and capsule
PH12015500384A1 (en) Polyolefin composition
ZA201703337B (en) Microcapsules containing a gas-generating photolabile polymer and uses thereof
EP2851059A4 (en) DEVICE FOR FILLING A MEDICAL AGENT
EP2905319A4 (en) TREATMENT AGENT AND COSMETIC MATERIAL CONTAINING A COMODIFIED ORGANOPOLYSILOXANE
BR112014029212A2 (pt) composição de agente de clarificação. composição de resina e artigo moldado
GB201317052D0 (en) Biodegradable material
GB201407760D0 (en) Vaporisable material and capsule
PT2895192T (pt) Uma composição farmacêutica compreendendo uma nanopartícula sólida e pelo menos um antígeno para o tratamento contra um agente patogénico intracelular
EP2940146A4 (en) HIGH-FUNCTIONAL IMPLANT MATERIAL
IL238788A0 (en) sema5b peptides and components containing them